A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 42,500 shares of RXRX stock, worth $307,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,500
Previous 46,000 7.61%
Holding current value
$307,700
Previous $345,000 18.84%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.92 - $8.6 $20,720 - $30,100
-3,500 Reduced 7.61%
42,500 $280,000
Q1 2024

May 15, 2024

BUY
$9.13 - $15.52 $419,980 - $713,920
46,000 New
46,000 $459 Million
Q3 2023

Aug 14, 2024

SELL
$6.59 - $15.86 $12,521 - $30,134
-1,900 Reduced 4.13%
44,100 $337 Million

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.31B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.